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Menorrhagia is a common disorder during the reproduc-
tive age. It often results from myometrial or endometrial
lesions. Menorrhagia caused by uterine arteriovenous
malformations (AVMs) is a rare but life-threatening
event. The major presentation of uterine AVMs is char-
acterized by painless, intermittent, abrupt and profuse
vaginal bleeding that is usually refractory to medical
treatment [1]. The appropriate management of AVMs
relies considerably on accurate diagnosis [2]. In order
to achieve a prompt diagnosis, it is essential to raise a
clinical suspicion of uterine AVMs in patients with unac-
countably intractable vaginal hemorrhage with specific
bleeding characteristics.
The patient was a 38-year-old woman, gravida 2,
para 2 (via cesarean section twice). Her last cesarean
delivery was twelve years prior to this presentation,
and her menstrual cycle had been regular without any
experience of excessive menstrual flow after the delivery.
She came to the emergency department complaining of
sudden intermittent, painless and profuse vaginal bleed-
ing with blood clots on the seventh day of her period.
Vaginal spotting was the only unusual sign shortly before
the event. She denied having any underlying hemato-
logic disorders or drug exposure such as hormonal
therapy. Pelvic sonography showed thin endometrium
without definite uterine tumors (Figure 1). On pelvic
examination, the appearances of the uterine cervix and
vagina were grossly normal without traumatic lesions
or tumor formations. However, there was intermittent
flow of blood gushing out from the endocervical canal,
and the amount of blood loss was approximately
500 mL within minutes. Results of coagulation studies
were within normal limits, and urine β-hCG test was
negative. Immediate hemodynamic resuscitation was
done, with intravenous fluids supplement and blood
component therapy. The hemorrhage was not responsive
to intravenous medicines such as transamines (oxytocin)
and uterotonics (methylergonovine). Subsequently, uter-
ine tamponade with a Foley balloon was performed,
and the bleeding gradually decreased. Eleven hours after
the balloon tamponade, she experienced a gush of pro-
fuse vaginal bleeding again. As uterine AVMs  were sus-
pected, pelvic angiography was recommended for further
diagnosis and treatment; however, the patient refused.
Finally, the couple opted for surgical hysterectomy to
avoid the possible failure of conservative treatment.
Gross examination of the uterine cavity revealed one
small vascular clump with laceration at the right isth-
mus (Figure 2A), and a well-defined hemorrhagic lesion
was found at the isthmus of the formalin-fixed uterine
wall (Figure 2B). Microscopic examination of the right
isthmus showed dilated and tortuous vessels with mixed
thick and thin vascular walls, which was consistent with
uterine AVMs (Figure 3). The hospital course of the
patient before the hysterectomy is summarized in the
Table. The postoperative course was uneventful, and
she was discharged on the fourth postoperative day.
During her hospitalization, she was transfused with 
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Figure 1. Transabdominal sonography reveals a well-defined
uterus with no tumors and a thin endometrium (blood clots
in the vagina).
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6 units of packed red blood cells and 6 units of fresh
frozen plasma.
AVMs are formed by large and dysplastic feeding
arteries, resulting in decreased vascular resistance.
Lesions in the uterus are very rare, and they can be
congenital or acquired lesions, with the latter often
associated with prior uterine surgery or pregnancy.
The major manifestation is abrupt, intermittent and
profuse vaginal hemorrhage associated with menometr-
orrhagia and immediate or delayed postpartum hem-
orrhage [1,3]. Hormonal changes are thought to trigger
the bleeding episode of uterine AVMs, such as those
seen during menstruation and pregnancy [4]. Because
of its life-threatening potential, uterine AVMs should
be highly suspected in patients who have experienced
an episode of unexplained vaginal hemorrhage with
specific bleeding patterns.
Prompt accurate diagnosis and appropriate treat-
ment are important. Uterine AVMs can be diagnosed
by using contrast-enhanced computed tomography,
magnetic resonance imaging, color Doppler ultrasonog-
raphy, angiography, and magnetic resonance angiog-
raphy [5,6]. Angiography is traditionally helpful in
making a definitive diagnosis and can determine the
vascular supply and guide embolization therapy. As soon
as the diagnosis is made, treatment should be started.
In the literature, several cases were successfully treated
with only medications such as methylergonovine and
prostaglandin F2α [7]. But heavy vaginal hemorrhage
often fails to respond to medical treatment if rupture
of uterine AVMs has occurred. Recently, conservative
management with laparoscopic bipolar coagulation of
the bilateral uterine vessels has been proposed as an
alternative approach [8]. Embolization performed simul-
taneously with angiography can be a good therapeutic
technique, and it is a promising option for preserving
future fertility after the procedure [9]. However, failure
of embolization may result from the recurrence of uter-
ine AVMs due to abundant collateral circulation and
revascularization. Surgical hysterectomy is inevitable and
reserved for the cessation of the uncontrollable uterine
bleeding. Therefore, the treatment of AVMs depends
on the severity of vaginal hemorrhage, the patient’s
age, and future reproductive desires. However, we dis-
cussed with the patient about the available treatment
options in the hospital; she still refused uterus-preserving
treatment such as angiography.
Figure 3. A well-circumscribed hemorrhagic area accompa-
nied by aggregates of thick- and thin-walled vessels at the
periphery (arrows) (hematoxylin and eosin, 100×).
A B
Figure 2. (A) One small vascular clump with laceration at the right uterine isthmian cavity (arrow). (B) A well-defined hemorrhagic
lesion at the isthmus of the formalin-fixed uterine wall (arrows).
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Our experience indicates that uterine AVM rupture
should be suspected in patients presenting with an
episode of intermittent, abrupt and heavy vaginal bleed-
ing without the detection of any source of bleeding
such as endometrial hyperplasia, and cervical or vagi-
nal lacerations. Temporary hemodynamic stabilization
of uterine AVMs rupture can be achieved by intrauter-
ine balloon tamponade. A Foley catheter is inexpensive,
readily available, and easily inserted into the uterine
cavity without any special techniques [10]. The proce-
dure is valuable while awaiting opportunity to per-
form a definitive treatment such as embolization or
hysterectomy. In addition, vaginal bleeding from the
abnormal vascular structure within the uterine cavity
(Figure 2A) may be aggravated by uterine instrument
usage such as dilatation and curettage; therefore, it is
important to be aware of this uncommon condition in
order to prevent additional excess uterine bleeding
from inappropriate procedures.
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